BB Biotech AG (SWX: BION)
Switzerland
· Delayed Price · Currency is CHF 37.95
-0.95 (-2.44%)
Sep 4, 2024, 5:30 PM CET
-7.44% (1Y)
| Market Cap | 2.08B |
| Revenue (ttm) | 192.96M |
| Net Income (ttm) | 234.14M |
| Shares Out | 54.85M |
| EPS (ttm) | 4.26 |
| PE Ratio | 8.91 |
| Forward PE | 9.88 |
| Dividend | 2.00 (5.14%) |
| Ex-Dividend Date | Mar 25, 2024 |
| Volume | 123,414 |
| Open | 38.35 |
| Previous Close | 38.90 |
| Day's Range | 37.60 - 38.55 |
| 52-Week Range | 35.35 - 49.80 |
| Beta | 0.84 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 25, 2024 |
About BION
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Country Switzerland
Stock Exchange SIX Swiss Exchange
Ticker Symbol BION
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 25, 2024 | 2.000 CHF | Mar 27, 2024 |
| Mar 27, 2023 | 2.850 CHF | Mar 29, 2023 |
| Mar 21, 2022 | 3.850 CHF | Mar 23, 2022 |
| Mar 22, 2021 | 3.600 CHF | Mar 24, 2021 |
| Mar 23, 2020 | 3.400 CHF | Mar 25, 2020 |
| Mar 25, 2019 | 3.050 CHF | Mar 27, 2019 |